Skip to content

International Women's Day 2023

International Women's Day 2023

International Women’s Day 2023

Scailyte celebrates International Women's Day 2023

Scailyte celebrates International Women’s day and praises all women Scailyters: smart, trailblazing individuals, with a can-do attitude and high integrity! With 55% of our team and two-thirds of C-level being women, Scailyte is a role model in the biotech sector and benefits from its diverse team – not even mentioning that this true diversity makes Scailyte a great place to work for everyone! 

Let’s continue supporting women in science, business, management and executive positions, and in all adventures worth embracing!

This is what our female employees say:

– Dzhansu Hasnova – “”We all get to the peak together or we don’t get there at all.”” – Hidden Figures, 2016

– Shaoline Sheppard – “”Women’s health needs to be front and center – it often isn’t, but it needs to be.”” – Cynthia Nixon

– Sreoshee Rafiq – “”The wave of change in the past decade in relation to gender equality, women empowerment and diversity has shaped our present and the coming future in a way that I am very appreciative of. However, care needs to be taken to ensure that these changes are permanent and not co-opted by corporations as a trend. I think what we sometimes forget is diversity does not automatically translate to inclusivity. The latter, to me, is a state of mind and cannot be achieved by merely existing. Yes, I am here but do I feel included? As a minority, I don’t want to become the face of token diversity. It is organic and sustainable only when I have a seat at the table, my voice is heard, my opinion is valued and I am included in the decision-making process. A diverse workforce is a strength to strive for, not a quota to be filled and that’s a reminder we carry with us at Scailyte.””

– Cinzia Donato – “I feel so lucky to be surrounded by so many feminists: at Scailyte women and, even more, men make the gender gap extremely thin. This is the right attitude to have when pioneering in the FemTech space”

– Sarah Carl – “”Having a daughter makes me even more determined to support women around me in science and leadership, to demonstrate to her that she should have no limitations to her ambitions!””

– Kashish Mallick – “”As an Indian woman who grew up in Switzerland, the more I had to work hard to be accepted in some environments, the more I grew to appreciate diverse cultural backgrounds being celebrated by others, such as in the workplace of Scailyte.””

– Diana Stoycheva – “”I celebrate the progressive environment at Scailyte as extremely empowering. I felt particularly empowered by our last team cooking activity when i enjoyed the food prepared by our male colleagues without having to cook myself 💪.””

– Corinne Solier – “”As a woman in science and leadership, I feel compelled to support all girls and women with talent and passion to believe in their dreams and strengths, and not to be afraid about not conforming with normative behaviors: our difference is our power!””

– Justyna Przystal – “”Anyone who has never made a mistake has never tried anything new.”” – A. Einstein

– Sahar Sala – “”Champions keep playing until they get it right”” – Billie Jean King

About Scailyte

Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex disease patterns from single-cell data. Our solution provides unprecedented insight into the disease and patients’ biology and enables the discovery of new clinically-relevant biomarker signatures by uncovering human’s hidden “single-cell” secrets. 

Scailyte’s proprietary best-in-class data analysis platform ScaiVision™ associates multimodal single-cell datasets (RNA-/TCR-/BCR-seq, proteomics, etc.) with clinical endpoints, such as disease diagnosis, progression, severity, treatment response, and toxicity response to identify ultra-sensitive biomarker signatures and cell functionality states. The performance and clinically-relevant applications of Scailyte’s platform ScaiVision have been demonstrated in well established CAR-T cell therapies and various clinical projects in Oncology and Immunology.

For more information, visit www.scailyte.com and connect on social media @LinkedIn and @Twitter.

ScailyteTM and ScaiVisionTM are registered trademarks proprietary to Scailyte AG.

Recent News

Scailyte is fundraising!

Scailyte is kicking off its new fundraising campaign! We are seeking like-minded investors who share...

Read more

Recent News

Scailyte and Visterra Partner to Advance Autoimmune Disease Research

Scailyte AG, an AI-driven biomarker discovery company, and Visterra, Inc., a clinical-stage biopharm...

Read more

Recent News

Precision Medicine and The Future of Genomics Summit 2024

Scailyte at the Global Stage of Precision Medicine – PMFG 2024! We are proud to share that our CEO...

Read more

Recent News

Exploring Type 2 T Cell Immunity in Cancer—A Single-Cell Revolution

In this issue of ScaiDigest, we highlight two groundbreaking studies that expand the boundaries of i...

Read more

Recent News

Pitch Nic 2024 at Novartis Campus

We’re thrilled to announce that our CEO, Peter Nestorov will join the innovative minds at Pitch Ni...

Read more

Recent News

Genomics for Health 2024

Don't miss Scailyte's CEO, Peter Nestorov, at the Genomics for Health 2024 event, bridging cutting-e...

Read more

Recent News

The Year of the AI Nobel

2024 is being hailed as the "Year of the AI Nobel," marking a milestone as artificial intelligence (...

Read more

Recent News

01 /04

Scailyte is fundraising!

Scailyte is kicking off its new fundraising campaign! We are seeking like-minded investors who share...

Read more

Scailyte and Visterra Partner to Advance Autoimmune Disease Research

Scailyte AG, an AI-driven biomarker discovery company, and Visterra, Inc., a clinical-stage biopharm...

Read more

Recent News

02 /04

Precision Medicine and The Future of Genomics Summit 2024

Scailyte at the Global Stage of Precision Medicine – PMFG 2024! We are proud to share that our CEO...

Read more

Exploring Type 2 T Cell Immunity in Cancer—A Single-Cell Revolution

In this issue of ScaiDigest, we highlight two groundbreaking studies that expand the boundaries of i...

Read more

Recent News

03 /04

Pitch Nic 2024 at Novartis Campus

We’re thrilled to announce that our CEO, Peter Nestorov will join the innovative minds at Pitch Ni...

Read more

Recent News

04 /04

Genomics for Health 2024

Don't miss Scailyte's CEO, Peter Nestorov, at the Genomics for Health 2024 event, bridging cutting-e...

Read more

The Year of the AI Nobel

2024 is being hailed as the "Year of the AI Nobel," marking a milestone as artificial intelligence (...

Read more

Recent News